We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
AUM
$195M
AUM Growth
+$7.89M
Cap. Flow
+$9.74M
Cap. Flow %
4.99%
Top 10 Hldgs %
100%
Holding
7
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
RXDX
Ignyta, Inc.
RXDX
+$9.74M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$1.7B
$88.3M 45.24%
3,688,448
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
$26.2M 13.42%
2,600,014
COLL icon
3
Collegium Pharmaceutical
COLL
$820M
$23.6M 12.1%
1,887,332
RXDX
4
DELISTED
Ignyta, Inc.
RXDX
$22.5M 11.53%
2,173,593
+1,199,900
+123% +$9.74M
IOVA icon
5
Iovance Biotherapeutics
IOVA
$3.74B
$15.2M 7.8%
2,188,331
CDTX
6
DELISTED
Cidara Therapeutics
CDTX
$9.84M 5.04%
65,613
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$9.49M 4.86%
202,803

Similar funds

Frazier Management's Q2 2017 Portfolio in Review

As of Q2 2017, Frazier Management held 7 positions worth $195M, up 4.2% from $187M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Frazier Management deployed $9.74M of net new capital in Q2 2017, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Frazier Management added most to Ignyta, Inc. in Q2 2017, an estimated $9.74M increase.
  • Frazier Management's ten largest holdings make up 100% of its $195M portfolio in Q2 2017.
  • Frazier Management opened 0 new positions and closed 0 in Q2 2017.
  • Frazier Management's portfolio value rose 4.2% quarter-over-quarter to $195M.

Based on Frazier Management's 13F filing for Q2 2017, filed 14 Aug 2017.